Jimi Kim

Dr. Jimi Kim

orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 September 2016 in Nature
Verified
Journal Article
Closed access
PDF file
JKJimi Kim
Jimi Kim
EMElizabeth McMillan
Elizabeth McMillan
HKHyun Seok Kim
Hyun Seok Kim
NVNiranjan Venkateswaran
Niranjan Venkateswaran
GMGurbani Makkar
Gurbani Makkar
MWMichael A. White
Michael A. White

1 October 2013 in Cell
Verified
Journal Article
Closed access
HKHyun Seok Kim
Hyun Seok Kim
SMSaurabh Mendiratta
Saurabh Mendiratta
JKJiyeon Kim
Jiyeon Kim
CPChad Victor Pecot
Chad Victor Pecot
JLJill E. Larsen
Jill E. Larsen
MWMichael A. White
Michael A. White

30 April 2009 in The EMBO Journal
Verified
Journal Article
Open access
PDF file
ECEunhee Choi
Eunhee Choi
HCHyerim Choe
Hyerim Choe
JMJaewon Min
Jaewon Min
JCJi Yoon Choi
Ji Yoon Choi
JKJimi Kim
Jimi Kim
HLHyunsook Lee
Hyunsook Lee
Regulation of BubR1 is central to the control of APC/C activity. We have found that BubR1 forms a complex with PCAF and is acetylated at lysine 250. Using mass spectrometry and acetylated BubR1‐specific antibodies, we have confirmed that BubR1 acetylation occurs at prometaphase. Importantly, BubR1 acetylation was required for checkpoint function, through the inhibition of ubiquitin‐dependent BubR1 degradation. BubR1 degradation began before the onset of anaphase. It was noted that the pre‐anaphase degradation was regulated by BubR1 acetylation. Degradation of an acetylation‐mimetic form, BubR1–K250Q, was inhibited and chromosome segregation in cells expressing BubR1–K250Q was markedly delayed. By contrast, the acetylation‐deficient mutant, BubR1–K250R, was unstable, and mitosis was accelerated in BubR1–K250R‐expressing cells. Furthermore, we found that APC/C–Cdc20 was responsible for BubR1 degradation during mitosis. On the basis of our collective results, we propose that the acetylation status of BubR1 is a molecular switch that converts BubR1 from an inhibitor to a substrate of the APC/C complex, thus providing an efficient way to modulate APC/C activity and mitotic timing. There is a [Have you seen ...?][1] (July 2009) associated with this Article. [1]: http://dx.doi.org/10.1038/emboj.2009.149

3 January 2019 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
HKHaedong Kim
Haedong Kim
JKJimi Kim
Jimi Kim
KKKijun Kim
Kijun Kim
HCHyeshik Chang
Hyeshik Chang
KYKwontae You
Kwontae You
VKV Narry Kim
V Narry Kim
MicroRNAs (miRNAs) modulate diverse biological and pathological processes via post-transcriptional gene silencing. High-throughput small RNA sequencing (sRNA-seq) has been widely adopted to investigate the functions and regulatory mechanisms of miRNAs. However, accurate quantification of miRNAs has been limited owing to the severe ligation bias in conventional sRNA-seq methods. Here, we quantify miRNAs and their variants (known as isomiRs) by an improved sRNA-seq protocol, termed AQ-seq (accurate quantification by sequencing), that utilizes adapters with terminal degenerate sequences and a high concentration of polyethylene glycol (PEG), which minimize the ligation bias during library preparation. Measurement using AQ-seq allows us to correct the previously misannotated 5′ end usage and strand preference in public databases. Importantly, the analysis of 5′ terminal heterogeneity reveals widespread alternative processing events which have been underestimated. We also identify highly uridylated miRNAs originating from the 3p strands, indicating regulations mediated by terminal uridylyl transferases at the pre-miRNA stage. Taken together, our study reveals the complexity of the miRNA isoform landscape, allowing us to refine miRNA annotation and to advance our understanding of miRNA regulation. Furthermore, AQ-seq can be adopted to improve other ligation-based sequencing methods including crosslinking-immunoprecipitation-sequencing (CLIP-seq) and ribosome profiling (Ribo-seq).

1 June 2020 in Molecular Cell
Verified
Journal Article
Closed access
HKHaedong Kim
Haedong Kim
JKJimi Kim
Jimi Kim
SYSha Yu
Sha Yu
YLYoung-Yoon Lee
Young-Yoon Lee
JPJunseong Park
Junseong Park
VKV. Narry Kim
V. Narry Kim

1 February 2012 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
JMJaewon Min
Jaewon Min
ECEun Shik Choi
Eun Shik Choi
KHKwangwoo Hwang
Kwangwoo Hwang
JKJimi Kim
Jimi Kim
SSSrihari Sampath
Srihari Sampath
HLHyunsook Lee
Hyunsook Lee
Inactivating mutations in the breast cancer susceptibility gene BRCA2 cause gross chromosomal rearrangements. Chromosome structural instability in the absence of BRCA2 is thought to result from defective homology-directed DNA repair. Here, we show that BRCA2 links the fidelity of telomere maintenance with genetic integrity. Absence of BRCA2 resulted in signs of dysfunctional telomeres, such as telomere shortening, erosions, and end fusions in proliferating mouse fibroblasts. BRCA2 localized to the telomeres in S phase in an ATR-dependent manner, and its absence resulted in the accumulation of common fragile sites, particularly at the G-rich lagging strand, and increased the telomere sister chromatid exchange in unchallenged cells. The incidence of common fragile sites and telomere sister chromatid exchange increased markedly after treatment with replication inhibitors. Congruently, telomere-induced foci were frequently observed in the absence of Brca2, denoting activation of the DNA damage response and abnormal chromosome end joining. These telomere end fusions constituted a significant portion of chromosome aberrations in Brca2-deficient cells. Our results suggest that BRCA2 is required for telomere homeostasis and may be particularly important for the replication of G-rich telomeric lagging strands.